Dr. Nausheen Fathima Mahmood, MD

Dr. Mahmood practices at UCSF Student Health and Counseling Services in San Francisco, California.

Dr. Mahmood's NPI, 1013408970, was assigned on May 25, 2018. Dr. Mahmood holds Washington license MD61556907.

Dr. Mahmood's primary practice is UCSF Student Health and Counseling Services, at 500 Parnassus Ave, San Francisco, CA 94143. The practice phone is (415) 476-1281.

Dr. Mahmood's primary practice is UCSF Student Health and Counseling Services in San Francisco, California. Dr. Mahmood is also affiliated with UW Medical Center - Montlake. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Mahmood to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mahmood practices, 3 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Mahmood's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Mahmood is licensed in Washington.

CMS data shows 21 Medicare services from Dr. Mahmood across 1 procedure code in 2024, for 36 Medicare patients. Medicare paid $3,645 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 36 Medicare patients who saw Dr. Mahmood in 2024. The largest group is 65 to 74, with 12 patients. 72% of them have high blood pressure, and 69% have high cholesterol. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mahmood's median patient age at 42, with 60% women.

In 2024, Dr. Mahmood wrote 76 Medicare Part D claims for 40 patients. 93% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $388 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Mahmood for performance year 2024, reported as part of a group. Dr. Mahmood accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mahmood as offering telehealth.

Dmand AI links 3 papers to Dr. Mahmood, published from 2021 to 2025. Dr. Mahmood's most frequent co-authors are Matthew R. Amans, MD, Josiah Bartlett Ambrose, MD and Daniel Lewis Cooke, MD.

CMS Open Payments shows 2 general payments to Dr. Mahmood from 2 drug and device companies in 2024. Travel and lodging make up the largest share, 65% of the total. Ceribell, Inc. paid the most, $500.